Wang Liangshan, Hao Xing, Wang Xiaomeng, Gu Chengxiong, Wang Hong, Hou Xiaotong
1 Center for Cardiac Intensive Care, Capital Medical University Affiliated Anzhen Hospital, Beijing, People's Republic of China.
2 Department of Cardiac Surgery, Capital Medical University Affiliated Anzhen Hospital, Beijing, People's Republic of China.
Perfusion. 2018 Sep;33(6):426-432. doi: 10.1177/0267659118759594. Epub 2018 Feb 16.
Coronary artery bypass grafting (CABG) combined with coronary endarterectomy (CE) can be associated with high operative mortality and morbidity. An intra-aortic balloon pump (IABP) has been the most widely used mechanical circulatory support device during perfusion treatment. However, the benefits of preoperative IABP in CABG combined with CE remain unknown. We conducted a retrospective observational study to evaluate the efficacy of preoperative IABP therapy in patients undergoing adjunctive right coronary artery (RCA) endarterectomy.
Between May 2013 and May 2016, 120 patients undergoing off-pump coronary artery bypass grafting (OPCABG) with RCA endarterectomy who received preoperative IABP support (IABP group, n=56) or who did not receive preoperative IABP support (control group, n=64) were evaluated retrospectively.
Patients in the IABP group had a significantly lower mean preoperative ejection fraction and a significantly higher mean EuroSCORE (both <0.05). The incidence of inferior myocardial infarction (MI) was significantly lower in the IABP group than in the control group (3.6% vs 15.6%, RR = 0.23, 95% CI 0.05-1.00, p=0.03). Hospital mortality was similar in the two groups (3.6% vs 4.7%, RR= 0.76, 95% CI 0.13-4.40, p=0.76). There were no significant differences between the two groups with respect to the rates of prolonged ventilation, low cardiac output syndrome, renal failure requiring dialysis, re-operation for bleeding or IABP-related complications. Preoperative IABP may be a protective factor of inferior MI (HR = 0.031, 95% CI 0.004-0.211, p<0.001) Conclusions: The preoperative use of IABP could reduce the incidence of postoperative MI in patients undergoing CABG with CE and seemed to shift high-risk patients into a lower-risk category.
冠状动脉旁路移植术(CABG)联合冠状动脉内膜切除术(CE)可能伴有较高的手术死亡率和发病率。主动脉内球囊泵(IABP)一直是灌注治疗期间使用最广泛的机械循环支持装置。然而,术前IABP在CABG联合CE中的益处仍不明确。我们进行了一项回顾性观察研究,以评估术前IABP治疗对接受右冠状动脉(RCA)内膜切除术患者的疗效。
回顾性评估2013年5月至2016年5月期间120例行非体外循环冠状动脉旁路移植术(OPCABG)并接受RCA内膜切除术的患者,其中接受术前IABP支持的患者(IABP组,n = 56)和未接受术前IABP支持的患者(对照组,n = 64)。
IABP组患者术前平均射血分数显著更低,平均欧洲心脏手术风险评估系统(EuroSCORE)显著更高(均P<0.05)。IABP组下壁心肌梗死(MI)的发生率显著低于对照组(3.6%对15.6%,RR = 0.23,95%CI 0.05 - 1.00,P = 0.03)。两组的住院死亡率相似(3.6%对4.7%,RR = 0.76,95%CI 0.13 - 4.40,P = 0.76)。两组在延长通气率、低心排血量综合征、需要透析的肾衰竭、因出血再次手术或IABP相关并发症发生率方面无显著差异。术前IABP可能是下壁MI的保护因素(HR = 0.031,95%CI 0.004 - 0.211,P<0.001)。结论:术前使用IABP可降低CABG联合CE患者术后MI的发生率,似乎能将高危患者转变为低危类别。